Samuel C. Blackman Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity
Samuel C. Blackman is HEAD OF R&D of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 1.13 Million shares of DAWN, which is worth approximately $16 Million. The most recent transaction as insider was on Dec 01, 2022, when has been sold 10,000 shares (Common Stock) at a price of $21.77 per share, resulting in proceeds of $217,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.13M
3.72%
3M change
8.8%
12M change
Total Value Held
$16 Million
Samuel C. Blackman Transaction History
SCB
Samuel C. Blackman
HEAD OF R&D
South San Francisco, CA